| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REPLIGEN CORP | Director | Common Stock | 793 | $130K | $163.34 | May 16, 2024 | Direct |
| REPLIGEN CORP | Director | Stock Option (Right to Buy) | 1.38K | May 16, 2024 | Direct | ||
| ALIMERA SCIENCES INC | Director | Stock Option (Right to Buy) | 0 | Sep 16, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALIM | ALIMERA SCIENCES INC | Sep 16, 2024 | 1 | $0 | 4 | Sep 18, 2024 | Director |
| RGEN | REPLIGEN CORP | May 16, 2024 | 2 | $0 | 4 | May 20, 2024 | Director |
| RGEN | REPLIGEN CORP | Mar 18, 2024 | 3 | $0 | 4 | Mar 19, 2024 | Director |
| RGEN | REPLIGEN CORP | Mar 18, 2024 | 0 | $0 | 3 | Mar 19, 2024 | Director |
| ALIM | ALIMERA SCIENCES INC | Nov 7, 2023 | 1 | $0 | 4 | Nov 8, 2023 | Director |
| ALIM | ALIMERA SCIENCES INC | Nov 7, 2023 | 0 | $0 | 3 | Nov 8, 2023 | Director |